Protein Tyrosine Kinases

9 个项目

每页

设置降序顺序
  1. JTE-952

    Catalog No. A18391
    Quick View
    CSF-1R 抑制剂
    TE-952 is a potent, oral active and selective Type II inhibitor of colony stimulating factor-1 receptor (CSF-1R or cFMS, type III receptor tyrosine kinase), with IC50 values of 13 nM and 261 nM for CSF1R and TrkA , respectively. Effective against a mouse collagen-induced model of arthritis. 了解更多
  2. AZD7507

    Catalog No. A16886
    Quick View
    CSF-1R 抑制剂
    AZD7507是一种有效的选择性CSF-1R抑制剂(32 nM细胞活性),AZD7507被认为是一种很有前途的化合物,因为它保留了AZ683所需的效能和口服药代动力学特性。 了解更多
  3. PLX5622

    Catalog No. A18888
    Quick View
    CSF1R inhibitor
    PLX5622 is a highly selective brain penetrant and oral active CSF1R inhibitor with an Ki of 5.9 nM, for extended and specific microglial elimination, preceding and during pathology development. 了解更多
  4. BLZ945

    Catalog No. A15540
    Quick View
    CSF1R 抑制剂
    BLZ945是有效的选择性CSF-1R激酶抑制剂。它减弱了TAM的周转率,同时增加了浸润宫颈癌和乳腺癌的CD8+ T细胞的数量。 了解更多
  5. Tandutinib (MLN518)

    Catalog No. A10887
    Quick View
    FLT3 抑制剂
    Tandutinib (MLN518)是一种有效的FLT3抑制剂,c-KIT和PDGF受体酪氨酸激酶的自磷酸化,从而抑制细胞增殖并诱导细胞凋亡。 了解更多
  6. Pexidartinib (PLX3397)

    Catalog No. A15520
    Quick View
    CSF1/Kit/FLT3 抑制剂
    Pexidartinib (PLX3397)是KIT,CSF1R和FLT3的小分子酪氨酸激酶(RTK)抑制剂,具有潜在的抗肿瘤活性。 了解更多
  7. Dovitinib Dilactic acid (TKI258 Dilactic acid)

    Catalog No. A10198
    Quick View
    RTK 抑制剂
    Dovitinib是一种小分子多靶点酪氨酸激酶抑制剂,可抑制通过ZNF198-FGFR1或BCR-FGFR1转化为IL3独立性的Ba / F3细胞,IC50值分别为150 nM和90 nM。 了解更多
  8. Dovitinib (TKI-258)

    Catalog No. A11411
    Quick View
    RTK 抑制剂
    Dovitinib是一种小分子多靶点酪氨酸激酶抑制剂,可抑制通过ZNF198-FGFR1或BCR-FGFR1转化为IL3独立性的Ba / F3细胞,IC50值分别为150 nM和90 nM。 了解更多
  9. Pazopanib (GW-786034)

    Catalog No. A11518
    Quick View
    VEGFR 抑制剂
    Pazopanib (GW-786034)是VEGFR-1,VEGFR-2,VEGFR-3,PDGFR-a/β和c-kit的有效且选择性的多靶点酪氨酸激酶抑制剂,可阻止肿瘤生长并抑制血管生成。 了解更多

9 个项目

每页

设置降序顺序
Rewards